Sleep
Sleep is not passive downtime for the brain — it is an active, biologically essential process during which the brain performs maintenance, consolidates memories, and clears out the metabolic waste that accumulates during waking hours. Chronic insufficient sleep is now recognized as a significant modifiable risk factor for dementia, and the evidence connecting poor sleep to accelerated brain aging has grown substantially over the past decade. A landmark study using 25 years of follow-up data from nearly 8,000 participants found that sleeping six hours or fewer per night at age 50 and 60 was associated with a 22–37% higher risk of developing dementia later in life, independent of mental health, cardiometabolic conditions, and other confounders (Sabia et al., 2021, Nature Communications). A broader 2024 meta-analysis of 31 longitudinal studies confirmed that short sleep duration is associated with a significantly elevated risk of dementia, particularly in shorter follow-up windows where reverse causation is less likely to explain the findings.
The most compelling mechanistic explanation for the sleep-dementia link involves the glymphatic system — the brain's dedicated waste clearance network, discovered in 2012. During sleep, cerebrospinal fluid flows through channels surrounding blood vessels, flushing out metabolic byproducts that accumulate during wakefulness — including amyloid-beta and tau, the proteins that form the plaques and tangles characteristic of Alzheimer's disease. A 2026 randomized crossover trial in humans directly demonstrated that glymphatic clearance of Alzheimer's disease biomarkers into the bloodstream is significantly enhanced during normal sleep compared to sleep deprivation, providing the first direct human evidence for the mechanism long established in animal models (Dagum et al., 2026, Nature Communications). In practical terms, this means that consistently shortchanging sleep may allow amyloid and tau to accumulate in the brain over years and decades — accelerating the very pathological processes that lead to Alzheimer's disease. It is worth noting that the precise details of when and how glymphatic clearance occurs remain an active area of research, but the overall evidence that sleep is essential for brain waste clearance is compelling.
Sleep disorders add another layer of risk. Obstructive sleep apnea — which affects an estimated 30–50% of older adults, most of them undiagnosed — disrupts the architecture of sleep, reduces slow-wave sleep (the stage during which glymphatic clearance is most active), and causes repeated episodes of oxygen deprivation that stress the brain's vascular system. Meta-analyses have found that sleep disorders broadly increase the risk of dementia, cognitive decline, and Alzheimer's disease. The good news is that sleep is one of the most actionable brain health factors: evidence-based strategies including sleep hygiene, cognitive behavioral therapy for insomnia (CBT-I), and treatment of sleep apnea with CPAP can meaningfully improve sleep quality, and screening and treatment of sleep apnea is one of the highest-value medical interventions available for brain health.
Want to go deeper? Module 7 of the Brain Health for Life course — Sleep & the Brain — covers the full science of sleep and brain health, explains the glymphatic system in plain language, walks through the evidence on sleep disorders and dementia risk, and provides a practical toolkit of evidence-based strategies for improving sleep quality. You'll also learn how to recognize the signs of sleep apnea and what to do about it.
Key References
Sabia, S., Fayosse, A., Dumurgier, J., et al. (2021). Association of sleep duration in middle and old age with incidence of dementia. Nature Communications, 12, 2289.
https://doi.org/10.1038/s41467-021-22354-2
Howard, C., Mukadam, N., Hui, E.K., & Livingston, G. (2024). The effects of sleep duration on the risk of dementia incidence in short and long follow-up studies: a systematic review and meta-analysis. Sleep Medicine, 124, 522–530.
https://doi.org/10.1016/j.sleep.2024.10.034
Dagum, P., et al. (2026). The glymphatic system clears amyloid beta and tau from brain to plasma in humans. Nature Communications.
https://doi.org/10.1038/s41467-026-68374-8
Iliff, J.J., Wang, M., Liao, Y., et al. (2012). A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Science Translational Medicine, 4(147), 147ra111.
https://doi.org/10.1126/scitranslmed.3003748
